MEM
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | DailyMed | PiHKAL | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | — | — | 2,5-DIMETHOXY-4-ETHOXYAMPHETAMINE | |
| Safety | ||||
| Dose · Oral | ||||
| Threshold | 15 mg | — | — | |
| Light | 15–25 mg | — | — | |
| Common | 25–35 mg | — | 20–50 mg | ≠ |
| Strong | 35–45 mg | — | — | |
| Duration | ||||
| Total | 8–16 hours | — | 10–14 hours | ≠ |
| After-effects | 1–12 hours | — | — | |
| Pharmacology | ||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
A rare stimulant, psychedelic and amphetamine discovered by Alexander Shulgin. Related to the DOx class of drugs, little is known about this obscure compound's pharmacology, however it is likely to be potent and have a long duration.
PiHKAL summary
A standout, dramatic, and reliably psychedelic compound of reasonably high potency, made by lengthening one substituent of TMA-2. Its discovery pinpointed the 4-position as the key "leverage point" that spawned many later potent 4-substituted families; the entry also argues for valuing potency because toxic thresholds in humans are unknown.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.